Stay updated on Pembrolizumab vs Methotrexate in Elderly Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab vs Methotrexate in Elderly Clinical Trial page.

Latest updates to the Pembrolizumab vs Methotrexate in Elderly Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoNo Change Detected
- Check15 days agoChange Detected- Added a government funding notice with operational details and links; - Updated version to v3.2.0; - Removed reference to v3.1.0.SummaryDifference4%

- Check22 days agoChange DetectedUpdate: version tag upgraded from v3.0.2 to v3.1.0, replacing the old revision with a new one. No other content changes detected.SummaryDifference0.1%

- Check36 days agoChange DetectedThe page revision is updated from v3.0.1 to v3.0.2, and the 'Back to Top' link was removed. No other substantive content changes were detected.SummaryDifference0.2%

- Check43 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1.SummaryDifference0.2%

- Check50 days agoChange DetectedThe page has undergone significant changes, including the addition of a facility name and location details, while several drug classifications and terms have been removed, including specific medications like methotrexate and pembrolizumab.SummaryDifference3%

- Check65 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab vs Methotrexate in Elderly Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Methotrexate in Elderly Clinical Trial page.